ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain

ClinicalTrials.gov ID: NCT05351801

Public ClinicalTrials.gov record NCT05351801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05351801
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
VA Office of Research and Development
Federal
Enrollment
320 participants

Conditions and interventions

Interventions

  • CBD (Epidolex) Drug
  • Placebo Drug
  • THC (Syndros) Drug
  • THC + CBD (Nabiximols) Drug

Drug

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2023
Primary completion
Sep 28, 2028
Completion
May 30, 2029
Last update posted
Feb 26, 2026

2023 – 2029

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
VA San Diego Healthcare System, San Diego, CA San Diego California 92161-0002 Recruiting
VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles California 90073-1003 Active, not recruiting
VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven Connecticut 06516-2770 Recruiting
Providence VA Medical Center, Providence, RI Providence Rhode Island 02908-4734 Recruiting
South Texas Health Care System, San Antonio, TX San Antonio Texas 78229-4404 Recruiting
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108-1532 Terminated

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05351801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05351801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →